Scott J. Bowen
Zoetis (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Protein Kinase Regulation and GTPase Signaling, Cannabis and Cannabinoid Research, Nerve injury and regeneration, Protein Degradation and Inhibitors
Most-Cited Works
- → Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain(2011)31 cited
- → Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: Identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds(2011)22 cited
- → Deciphering the Allosteric Binding Mechanism of the Human Tropomyosin Receptor Kinase A (hTrkA) Inhibitors(2019)17 cited
- → Pro region engineering of nerve growth factor by deep mutational scanning enables a yeast platform for conformational epitope mapping of anti‐NGF monoclonal antibodies(2018)16 cited
- → Structure based design of novel irreversible FAAH inhibitors(2009)11 cited
- → In Pursuit of an Allosteric Human Tropomyosin Kinase A (hTrkA) Inhibitor for Chronic Pain(2021)8 cited
- → Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA)(2019)6 cited
- → Lead identification and characterization of hTrkA type 2 inhibitors(2019)5 cited
- → Synthetic inhibitor leads of human tropomyosin receptor kinase A (hTrkA)(2020)4 cited
- → Pro region engineering of nerve growth factor by deep mutational scanning enables a yeast platform for conformational epitope mapping of anti-NGF monoclonal antibodies(2018)1 cited